university of
pittsburgh

department of psychiatry (wpic)

sweet laboratory
home

Research Projects
For Patients and Families
Publications
Training Opportunities
Links
Contact Us

 

 

Last Updated:

June 29, 2007

Recent Publications

  Alzheimer Disease

 Schizophrenia

Late Life Mood Disorders

 

Recent publications from our group, sorted by topic and year, can be found by clicking on the links above. To request reprints of any of our publications click on the title to link out to PubMed or the publishers' web sites, or you can contact us to Request A Reprint.

To view all of Dr. Sweet's publications on PubMed, click here.

 

 

 

 

Alzheimer Disease

2007

Prediction of psychosis onset in Alzheimer disease: The role of depression symptom severity and the HTR2A T102C polymorphism

2006

Prediction of Psychosis Onset In Alzheimer Disease: The Role of Cognitive Impairment, Depressive Symptoms, and Further Evidence for Psychosis Subtypes

 

2005

Alzheimer Disease Subjects With Psychosis Have Increased Schizotypal Symptoms Before Dementia Onset

Catechol-O-Methyltransferase Haplotype Is Associated With Psychosis In Alzheimer Disease.

Neuregulin-1 Polymorphism in Late Onset Alzheimer’s Disease Families with Psychoses

Heritability of Psychosis in Alzheimer's Disease.

Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.

Non-cognitive symptoms in mild cognitive impairment subjects.

 

2004

Alzheimer Disease with psychosis: Excess cognitive impairment is restricted to the misidentification subtype.

 

2003

Plasma and cerebrospinal fluid alpha 1-antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment.

Patterns of change in the treatment of psychiatric symptoms in patients with probable Alzheimer's disease from 1983 to 2000.

Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease.

Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.

Psychotic symptoms in Alzheimer disease: evidence for subtypes.

Taking a New Look at Psychosis in Alzheimer's Disease

 

2002

Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer disease.

Increased familial risk of the psychotic phenotype of Alzheimer disease. 

Linkage analysis of Alzheimer Disease with psychosis.

Research evaluation and prospective diagnosis of dementia with Lewy bodies.

Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology.

 

2001

The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer’s disease. 

The 5-HTTPR polymorphism and aggressive behavior in Alzheimer disease.

Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis.

 

2000

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II.

Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features.

 

1998

Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease.

 

 

Schizophrenia

2006

Regional specificity of chandelier neuron axon terminal alterations in schizophrenia.

 

2005

Mapping Auditory Core, Lateral Belt, and Parabelt Cortices In The Human Superior Temporal Gyrus.

 

2004

Pyramidal cell reduction in schizophrenia: evidence for involvement of auditory feedforward circuits.

 

2003

Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons.

Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia.

 

 

 

Late Life Mood Disorders

2004

Neuropathologic Correlates of Late-Onset Major Depression.

 

2003

APOE is associated with age-of-onset, but not cognitive functioning, in late life depression.

 

2002

The establishment of a brain bank for the study of late-life depression: a feasibility study of factors facilitating consent

 

2001

A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients.

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.

 

1997

Mortality of elderly patients with psychiatric disorders.

 

Back to Top